Clinical Trial Update: A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares saroGLitazar to pioglitazone in nonalcoholic fatty liver disease; the study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Saroglitazar (saroglitazar)

Snippet

Sponsor: Command Hospital, India | Conditions: Fatty Liver | Phase 3 | Status: UNKNOWN